These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 18770646)

  • 1. Flow cytometric FRET analysis of ErbB receptor tyrosine kinase interaction.
    Diermeier-Daucher S; Brockhoff G
    Curr Protoc Cytom; 2008 Jul; Chapter 12():Unit12.14. PubMed ID: 18770646
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidermal growth factor receptor, c-erbB2 and c-erbB3 receptor interaction, and related cell cycle kinetics of SK-BR-3 and BT474 breast carcinoma cells.
    Brockhoff G; Heiss P; Schlegel J; Hofstaedter F; Knuechel R
    Cytometry; 2001 Aug; 44(4):338-48. PubMed ID: 11500850
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidermal growth factor receptor coexpression modulates susceptibility to Herceptin in HER2/neu overexpressing breast cancer cells via specific erbB-receptor interaction and activation.
    Diermeier S; Horváth G; Knuechel-Clarke R; Hofstaedter F; Szöllosi J; Brockhoff G
    Exp Cell Res; 2005 Apr; 304(2):604-19. PubMed ID: 15748904
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The ErbB/HER family of protein-tyrosine kinases and cancer.
    Roskoski R
    Pharmacol Res; 2014 Jan; 79():34-74. PubMed ID: 24269963
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The efficacy of ErbB receptor-targeted anticancer therapeutics is influenced by the availability of epidermal growth factor-related peptides.
    Motoyama AB; Hynes NE; Lane HA
    Cancer Res; 2002 Jun; 62(11):3151-8. PubMed ID: 12036928
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The relative role of ErbB1-4 receptor tyrosine kinases in radiation signal transduction responses of human carcinoma cells.
    Bowers G; Reardon D; Hewitt T; Dent P; Mikkelsen RB; Valerie K; Lammering G; Amir C; Schmidt-Ullrich RK
    Oncogene; 2001 Mar; 20(11):1388-97. PubMed ID: 11313882
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the dimerization profiles of HER tyrosine kinases by time-resolved Förster resonance energy transfer (TR-FRET).
    Lopez-Crapez E; Ho-Pun-Cheung A; Garnero P; Bazin H
    Methods Mol Biol; 2015; 1233():45-55. PubMed ID: 25319888
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An update of the mechanisms of resistance to EGFR-tyrosine kinase inhibitors in breast cancer: Gefitinib (Iressa) -induced changes in the expression and nucleo-cytoplasmic trafficking of HER-ligands (Review).
    Ferrer-Soler L; Vazquez-Martin A; Brunet J; Menendez JA; De Llorens R; Colomer R
    Int J Mol Med; 2007 Jul; 20(1):3-10. PubMed ID: 17549382
    [TBL] [Abstract][Full Text] [Related]  

  • 9. EGF-induced redistribution of erbB2 on breast tumor cells: flow and image cytometric energy transfer measurements.
    Nagy P; Bene L; Balázs M; Hyun WC; Lockett SJ; Chiang NY; Waldman F; Feuerstein BG; Damjanovich S; Szöllosi J
    Cytometry; 1998 Jun; 32(2):120-31. PubMed ID: 9627225
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative characterization of the large-scale association of ErbB1 and ErbB2 by flow cytometric homo-FRET measurements.
    Szabó A; Horváth G; Szöllosi J; Nagy P
    Biophys J; 2008 Aug; 95(4):2086-96. PubMed ID: 18487307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Flow cytometric FRET analysis of erbB receptor interaction on a cell-by-cell basis.
    Diermeier-Daucher S; Hasmann M; Brockhoff G
    Ann N Y Acad Sci; 2008; 1130():280-6. PubMed ID: 18596360
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epiregulin binds to epidermal growth factor receptor and ErbB-4 and induces tyrosine phosphorylation of epidermal growth factor receptor, ErbB-2, ErbB-3 and ErbB-4.
    Komurasaki T; Toyoda H; Uchida D; Morimoto S
    Oncogene; 1997 Dec; 15(23):2841-8. PubMed ID: 9419975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Signal transduction of erbB receptors in trastuzumab (Herceptin) sensitive and resistant cell lines: local stimulation using magnetic microspheres as assessed by quantitative digital microscopy.
    Friedländer E; Arndt-Jovin DJ; Nagy P; Jovin TM; Szöllosi J; Vereb G
    Cytometry A; 2005 Oct; 67(2):161-71. PubMed ID: 16163699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The ErbB/HER receptor protein-tyrosine kinases and cancer.
    Roskoski R
    Biochem Biophys Res Commun; 2004 Jun; 319(1):1-11. PubMed ID: 15158434
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Growth stimulation of non-small cell lung cancer cell lines by antibody against epidermal growth factor receptor promoting formation of ErbB2/ErbB3 heterodimers.
    Maegawa M; Takeuchi K; Funakoshi E; Kawasaki K; Nishio K; Shimizu N; Ito F
    Mol Cancer Res; 2007 Apr; 5(4):393-401. PubMed ID: 17426253
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ErbB receptor tyrosine kinase network inhibition radiosensitizes carcinoma cells.
    Contessa JN; Abell A; Valerie K; Lin PS; Schmidt-Ullrich RK
    Int J Radiat Oncol Biol Phys; 2006 Jul; 65(3):851-8. PubMed ID: 16751066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ERBB receptor signaling promotes ependymoma cell proliferation and represents a potential novel therapeutic target for this disease.
    Gilbertson RJ; Bentley L; Hernan R; Junttila TT; Frank AJ; Haapasalo H; Connelly M; Wetmore C; Curran T; Elenius K; Ellison DW
    Clin Cancer Res; 2002 Oct; 8(10):3054-64. PubMed ID: 12374672
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An unexpected biochemical and functional interaction between gp130 and the EGF receptor family in breast cancer cells.
    Grant SL; Hammacher A; Douglas AM; Goss GA; Mansfield RK; Heath JK; Begley CG
    Oncogene; 2002 Jan; 21(3):460-74. PubMed ID: 11821958
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The neuregulin-I/ErbB signaling system in development and disease.
    Britsch S
    Adv Anat Embryol Cell Biol; 2007; 190():1-65. PubMed ID: 17432114
    [TBL] [Abstract][Full Text] [Related]  

  • 20. AEE788: a dual family epidermal growth factor receptor/ErbB2 and vascular endothelial growth factor receptor tyrosine kinase inhibitor with antitumor and antiangiogenic activity.
    Traxler P; Allegrini PR; Brandt R; Brueggen J; Cozens R; Fabbro D; Grosios K; Lane HA; McSheehy P; Mestan J; Meyer T; Tang C; Wartmann M; Wood J; Caravatti G
    Cancer Res; 2004 Jul; 64(14):4931-41. PubMed ID: 15256466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.